Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMerit Group Regulatory News (MRIT)

  • There is currently no data for MRIT

Trading Update

21 Oct 2024 07:00

RNS Number : 8589I
Merit Group PLC
21 October 2024
 

21 October 2024

Merit Group Plc

("Merit", the "Company" or the "Group")

Trading Update

Merit Group Plc (AIM: MRIT), the AIM-listed data and intelligence business, today issues an update on trading for the 6 months ended 30 September 2024 (H1:FY25) and the expected performance for the full financial year ended 31 March 2025 (FY25).

The Group expects to report revenues in H1:FY25 of approximately £9.3m, down 6.0% on the £9.9m reported for the comparative H1:FY24 period, and Adjusted EBITDA1 of around £1.2 million (H1:FY24 £1.8m).

The Group had net debt of £2.3m as at 30 September 2024 (30 September 2023: £2.5m, 31 March 2024: £1.9m) with available facilities of £3.7m.

Whilst trading of the Dods Political Intelligence business continues to perform in line with management's expectations, the revenues of MD&T in the period have fallen by 8.5% year-on-year, as projects within the Software & Technology Resourcing division have reached their conclusion and conversion of the sales pipeline for new work has fallen short of expectations with both macro and local factors impacting prospects' willingness to commit to scale IT projects.

Based on current trading, Revenue for the full year to 31 March 2025 is now expected to be around £18.5m (8% down year-on-year) and Adjusted EBITDA1 around £2.0 million, each approximately 10% and 40% below market expectations2, respectively. The loss before tax and non-recurring items for the year is expected to amount to £0.8m (FY24: Profit of £1.2m).

Despite recent challenges, the underlying market demand for data and data-related technology is forecast to continue to grow in the coming years and the Board believes that MD&T is well positioned to benefit from this structural market growth. The Board has taken steps to strengthen sales and marketing capabilities across the Group and expects to see growth in the sales pipeline and an improvement in prospect conversion over the next 18 months. The Board is confident of returning revenue to growth in the year to 31 March 2026 and, with the Company's strong operational gearing, expects to report a strong return to profitability.

Commenting on the results, CEO & CFO Phil Machray said: "Clearly the current dip in revenues combined with the additional cost of our investment in sales & marketing will have an impact on profitability in the short-term. Our focus remains on strong operational management, whilst pursuing revenue and earnings growth, and the Board remains confident in the longer term outlook of the business."

 

1 Adjusted EBITDA is calculated as earnings before tax, depreciation, amortisation of intangible assets, share based payments and non-recurring items.

2 Based on the £20.7 million revenue and £3.4m Adjusted EBITDA forecast contained in the most recent broker's research note, published on 18 July 2024.

Further information on the Company can be found at www.meritgroupplc.com.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

Merit Group plc

Mark Smith - Chairman

Phil Machray - CEO and CFO

 

020 7593 5500

020 7593 5518

Canaccord Genuity Limited (Nomad and Broker)

Bobbie Hilliam

Harry Pardoe

020 7523 8150

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANEEASALFFA
12
Date   Source Headline
5th Mar 20257:00 amRNSCancellation - MERIT GROUP PLC
25th Feb 202511:03 amRNSResult of General Meeting
3rd Feb 20254:00 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNSRecommended cancellation of listing & Notice of GM
14th Jan 202510:46 amRNSNotice of Requisition of General Meeting
13th Nov 20247:00 amRNSInterim Results
21st Oct 20247:01 amRNSDirectorate Change
21st Oct 20247:00 amRNSTrading Update
25th Sep 20247:00 amRNSResult of AGM
7th Aug 202410:31 amRNSPosting of Annual Report & Accounts
18th Jul 20247:00 amRNSFinal Results
24th May 202411:25 amRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSDirector/PDMR Shareholding
10th May 202411:52 amRNSDirector/PDMR Shareholding
10th May 20247:00 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSDirectorate Change
25th Apr 20247:00 amRNSTrading Update
28th Feb 20247:00 amRNSDirectorate Change
26th Jan 20247:00 amRNSBoard Change
8th Nov 20237:00 amRNSInterim Results
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
29th Sep 202310:30 amRNSResult of AGM
22nd Sep 20233:10 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
7th Sep 20231:30 pmRNSPosting of Annual Report and Notice of AGM
6th Sep 20237:30 amRNSFinal Results
19th Jul 20237:00 amRNSChange of registered address
4th May 20237:00 amRNSTrading Update
27th Mar 20237:00 amRNSLease Disposal
31st Jan 20237:00 amRNSDirectorate Change
12th Jan 202310:33 amRNSDisposal of Le Trombinoscope
13th Dec 20221:55 pmRNSDirectorate Change
1st Dec 20227:01 amRNSCompletion of the Disposal of Dods MET Operations
1st Dec 20227:00 amRNSInterim results
27th Oct 20227:00 amRNSDisposal of Media, Events and Training Operations
21st Sep 20223:15 pmRNSResult of AGM
11th Aug 202210:00 amRNSPosting of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSFinal Results
28th Apr 20227:00 amRNSTrading Update
28th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 202210:05 amRNSDirector/PDMR Shareholding
14th Dec 20211:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20211:15 pmRNSDirector/PDMR Shareholding
19th Nov 20215:00 pmRNSDirector/PDMR Shareholding
17th Nov 20213:15 pmRNSPerformance Share Plan
17th Nov 20217:00 amRNSHalf-year Report
10th Nov 202110:30 amRNSNotice of Half Year Results
1st Oct 20218:01 amRNSDirector/PDMR Shareholding
30th Sep 202112:45 pmRNSResult of AGM and GM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.